CYPSX
Price
$61.42
Change
-$0.65 (-1.05%)
Updated
Feb 4 closing price
Net Assets
25.83M
RYVLX
Price
$641.52
Change
-$23.50 (-3.53%)
Updated
Feb 4 closing price
Net Assets
1.28B
Interact to see
Advertisement

CYPSX vs RYVLX

Header iconCYPSX vs RYVLX Comparison
Open Charts CYPSX vs RYVLXBanner chart's image
ProFunds Consumer Disctnry Ultra Sec Svc
Price$61.42
Change-$0.65 (-1.05%)
VolumeN/A
Net Assets25.83M
Rydex NASDAQ-100® 2x Strategy A
Price$641.52
Change-$23.50 (-3.53%)
VolumeN/A
Net Assets1.28B
CYPSX vs RYVLX Comparison Chart in %
View a ticker or compare two or three
VS
CYPSX vs. RYVLX commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYPSX is a Buy and RYVLX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RYVLX has more cash in the bank: 1.28B vs. CYPSX (25.8M). CYPSX (0.00) and RYVLX (0.00) have matching dividends . CYPSX was incepted earlier than RYVLX: CYPSX (22 years) vs RYVLX (21 years). CYPSX (2.62) is less costly to investors than RYVLX (1.87). RYVLX is a more actively managed with annual turnover of: 383.00 vs. CYPSX (264.00). RYVLX has a lower initial minimum investment than CYPSX: RYVLX (2500) vs CYPSX (15000). RYVLX annual gain was more profitable for investors over the last year : 18.65 vs. CYPSX (2.06). RYVLX return over 5 years is better than : 82.35 vs. CYPSX (10.03).
CYPSXRYVLXCYPSX / RYVLX
Total Expense Ratio2.621.74151%
Annual Report Gross Expense Ratio2.621.87140%
Fund Existence22 years21 years-
Gain YTD1.388-0.015-9,237%
Front LoadN/A5%-
Min. Initial Investment150002500600%
Min. Initial Investment IRA15000N/A-
Net Assets25.8M1.28B2%
Annual Yield % from dividends0.000.00-
Returns for 1 year2.0618.6511%
Returns for 3 years67.89169.1540%
Returns for 5 years10.0382.3512%
Returns for 10 years189.281025.7018%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MRKR1.850.14
+8.19%
Marker Therapeutics
WTTR12.220.31
+2.60%
Select Water Solutions
CHRS2.220.05
+2.30%
Coherus Oncology Inc
ARM104.55-2.38
-2.23%
Arm Holdings plc
GPCR83.78-6.06
-6.75%
Structure Therapeutics